New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody. More than two decades ago, a small group of women with advanced breast cancer took part in a clinical trial testing a vaccine. All of [...]from SciTechDaily https://ift.tt/m1gc43v
